Omda AS (OMDA) investor relations material

Executive summary

• Achieved 16% year-over-year revenue growth in Q2 2025, with results in line with or exceeding guidance and strong performance across all business areas.

• EBITDA margin improved to 19% in Q2 2025, more than doubling from the previous year, and 20% year-to-date.

• Recurring revenue reached a record NOK 96 million in Q2, now 79% of total revenue, enhancing predictability and long-term value.

• Business model is highly diversified, with over 750 active contracts in 26 countries and a focus on specialized healthcare and emergency response software.

• Strategic focus on organic growth, efficient integration of acquisitions, and targeted M&A, primarily in the Nordics.

Financial highlights

• Q2 2025 revenue reached NOK 121.3 million, up 16% year-over-year, with H1 2025 revenue totaling NOK 243 million.

• Organic growth in constant currency was 7%, within the guided range of 5% to 10%.

• EBITDA for Q2 2025 was NOK 23 million, with a margin of 19%, and professional services revenue grew 35% year-over-year.

• Recurring revenues reached a record NOK 96 million in Q2, accounting for 79% of total revenue.

• Net working capital improved to -23% of sales, reflecting strong cash management.

Outlook and guidance

• 2025 revenue guidance set at NOK 460–485 million, with 2026 guidance at NOK 500–525 million, and EBITDA margin guidance of 23–27% for 2025.

• 2026 guidance maintained: top line over NOK 500 million and EBITDA margin between 28% and 32%.

• Targeting organic growth of 5–10% and inorganic growth of 10–20% annually.

• CapEx expected to remain around 10% of revenue, focused on software development.

• Continued focus on organic growth and targeted M&A to double revenues and expand margins.